Qasim M. Janjua

Qasim M. Janjua

Auto-generated profile, based on publicly available information

Qasim M. Janjua

Department of Physiology and Biophysics, College of Medicine and Health Sciences, National University of Science and Technology, Sohar, Oman

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2018 in Nature Genetics
Verified
Journal Article
Open access
SSSadia Saeed
Sadia Saeed
ABAmélie Bonnefond
Amélie Bonnefond
FTFilippo Tamanini
Filippo Tamanini
MUHAMMAD Usman MIRZAMUHAMMAD Usman MIRZA
MUHAMMAD Usman MIRZA
JMJaida Manzoor
Jaida Manzoor
PFPhilippe Froguel
Philippe Froguel
Study of monogenic forms of obesity has demonstrated the pivotal role of the central leptin-melanocortin pathway in controlling energy balance, appetite and body weight 1 . The majority of loss-of-function mutations (mostly recessive or co-dominant) have been identified in genes that are directly involved in leptin-melanocortin signaling. These genes, however, only explain obesity in <5% of cases, predominantly from outbred populations 2 . We previously showed that, in a consanguineous population in Pakistan, recessive mutations in known obesity-related genes explain ~30% of cases with severe obesity3-5. These data suggested that new monogenic forms of obesity could also be identified in this population. Here we identify and functionally characterize homozygous mutations in the ADCY3 gene encoding adenylate cyclase 3 in children with severe obesity from consanguineous Pakistani families, as well as compound heterozygous mutations in a severely obese child of European-American descent. These findings highlight ADCY3 as an important mediator of energy homeostasis and an attractive pharmacological target in the treatment of obesity.

21 January 2022 in Diabetes
Verified
Journal Article
Open access
PDF file
SSSadia Saeed
Sadia Saeed
QJQasim M. Janjua
Qasim M. Janjua
AHAttiya Haseeb
Attiya Haseeb
RKRoohia Khanam
Roohia Khanam
EDEmmanuelle Durand
Emmanuelle Durand
PFPhilippe Froguel
Philippe Froguel
Recent advances in genetic analysis have significantly helped in progressively attenuating the heritability gap of obesity and have brought into focus monogenic variants that disrupt the melanocortin signaling. In a previous study, next-generation sequencing revealed a monogenic etiology in ∼50% of the children with severe obesity from a consanguineous population in Pakistan. Here we assess rare variants in obesity-causing genes in young adults with severe obesity from the same region. Genomic DNA from 126 randomly selected young adult obese subjects (BMI 37.2 ± 0.3 kg/m2; age 18.4 ± 0.3 years) was screened by conventional or augmented whole-exome analysis for point mutations and copy number variants (CNVs). Leptin, insulin, and cortisol levels were measured by ELISA. We identified 13 subjects carrying 13 different pathogenic or likely pathogenic variants in LEPR, PCSK1, MC4R, NTRK2, POMC, SH2B1, and SIM1. We also identified for the first time in the human, two homozygous stop-gain mutations in ASNSD1 and IFI16 genes. Inactivation of these genes in mouse models has been shown to result in obesity. Additionally, we describe nine homozygous mutations (seven missense, one stop-gain, and one stop-loss) and four copy-loss CNVs in genes or genomic regions previously linked to obesity-associated traits by genome-wide association studies. Unexpectedly, in contrast to obese children, pathogenic mutations in LEP and LEPR were either absent or rare in this cohort of young adults. High morbidity and mortality risks and social disadvantage of children with LEP or LEPR deficiency may in part explain this difference between the two cohorts.

1 December 2015 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
QJQasim M. Janjua
Qasim M. Janjua
ASAdeela Shahid
Adeela Shahid
RARabail Alam
Rabail Alam
MRMarvi Rizwan
Marvi Rizwan
SSSadia Saeed
Sadia Saeed
MAMuhammad Arslan
Muhammad Arslan

28 February 2025 in medRxiv
Verified
Preprint
Open access
PDF file
SSSadia Saeed
Sadia Saeed
ASAnna-Maria Siegert
Anna-Maria Siegert
YTY.C. Loraine Tung
Y.C. Loraine Tung
RKRoohia Khanam
Roohia Khanam
QJQasim M. Janjua
Qasim M. Janjua
GYGiles S.H. Yeo
Giles S.H. Yeo
Up to 10% of patients with severe early-onset obesity carry pathogenic variants in known obesity-related genes, mostly affecting the leptin-melanocortin pathway. Studying children with severe obesity from consanguineous populations provides a unique opportunity to uncover novel molecular mechanisms. Using whole-exome sequencing, followed by a rigorous analytical and filtration strategy, we identified three different homozygous missense variants in SREK1 (encoding Splicing Regulatory glutamic acid and lysine rich protein) in children with severe obesity, from three unrelated consanguineous pedigrees. The wild type SREK1 gene of human induced pluripotent stem cell (iPSC)-derived hypothalamic neurons was individually replaced by each of the three variants and the impact of these changes on global gene expression was studied. Neurons expressing the two variants in the SREK1 RNA recognition domain p.P95L and p.T194M, but not the C-terminally located p.E601K, had markedly reduced expression of the small nucleolar RNA clusters SNORD115 and SNORD116 , deficiency of which has been implicated in Prader-Willi syndrome (PWS). In addition to hyperphagic obesity the carriers of these two variants had other features of PWS, such as neonatal hypotonia. In conclusion, homozygous variants in SREK1 result in a subtype of severe early onset obesity sharing features with PWS.

13 March 2026 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
QJQasim M. Janjua
Qasim M. Janjua
RKRoohia Khanam
Roohia Khanam
SSSadia Saeed
Sadia Saeed
JMJaida Manzoor
Jaida Manzoor
AHAttiya Haseeb
Attiya Haseeb
PFPhilippe Froguel
Philippe Froguel
Objective: Chronic obesity is associated with impaired bone health. However, few investigations have been conducted to assess bone physiology in early-onset obesity. In this study, we measured specific bone turnover and metabolic biomarkers in children with severe obesity with biallelic loss-of-function variants of the leptin ( LEP) , leptin receptor (LEPR) , or melanocortin 4 receptor ( MC4R) genes. Methods: Thirty-nine children aged 0.3–8.8 years with a BMI SDS ≥ 3, previously identified with pathogenic variants in LEP , LEPR , or MC4R , were recruited for the current study. Additionally, 13 age-matched children with severe obesity who tested negative for variants in known obesity-related genes were included, and another 13 unrelated age-matched children with normal body weight served as the control group. Serum osteocalcin, osteopontin, osteoprotegerin, and sclerostin levels were assessed using multi-analyte profiling. Serum leptin, insulin, and cortisol levels were determined using ELISA. Results: Serum levels of osteocalcin and osteopontin, specific markers of bone formation, were significantly lower in children with LEP and LEPR biallelic variants than in the control group. In contrast, the values of these two biomarkers in children with MC4R deficiency were significantly higher than those in the other groups. No differences were observed in the bone resorption markers osteoprotegerin and sclerostin. Hyperleptinemia was more pronounced in children with LEPR deficiency. Serum insulin concentrations were elevated in individuals with MC4R deficiency, whereas serum cortisol levels were significantly higher in children with LEP deficiency than in all other groups. Conclusion: Our data demonstrate that osteogenic activity (but not resorption activity) is differentially affected in children with complete genetic disruption of the leptin-signaling pathway. Children with MC4R deficiency showed higher osteogenic markers, but children with LEP and LEPR deficiencies showed the opposite. Our results support the usefulness of bone turnover biomarkers for the assessment and management of bone health in different types of obesity. Keywords: Monogenic obesity, Bone metabolism biomarkers, LEP, LEPR, MC4R